- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01297075
Outreach Visits to Optimize Chronic Care Management in General Practice: A Cluster Randomized Trial (Output)
The aim of this project is to motivate and support general practice clinics in implementing the visions and recommendations presented in two of the disease specific programmes for chronic care management (for chronic obstructive lung disease and Type 2 diabetes). These programmes describe evidence based treatment and division of tasks between the municipalities, the hospitals and general practice.
The Facilitator Project is funded by The Danish Ministry of Interior and Health.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Capital
-
Copenhagen, Capital, Denmark, 1014
- Research Unit of General Practice
-
-
Capital Area
-
Copenhagen, Capital Area, Denmark, 1014
- Frans Boch Waldorff
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
General Practices working in the capital region in Denmark
Exclusion Criteria:
General Practices where the facilitator works.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Outreach visits
Practices allocated to outreach visits may receive up to three outreach visits in order to motivate and support general practice clinics in implementing two chronic care programmes for chronic obstructive Pulmonary disease and Type 2 diabetes.
|
The 16 facilitators in the project attend an educational programme designed to provide them with the necessary skills and tools for the task.
The facilitators visit general practice clinics from March 2011 until the end of 2012.
Each clinic is offered three visits.
The facilitator is to act as a change agent who motivates and helps the clinic team in the process of defining common goals, and choosing the appropriate means for achieving them.
|
|
No Intervention: Control (late intervention)
These practices are allocated to outreach visits after the initial evaluation stops at 12 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline at 12 month in Annual systematic chronic disease follow up consultations
Time Frame: Month 4, 3, 2 before baseline and month 13,14,15 after baseline (after intervention)
|
Change in annual systematic chronic disease controls per person affiliated with a primary care at a period at baseline and at 12 month.
|
Month 4, 3, 2 before baseline and month 13,14,15 after baseline (after intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ICPC diagnosis coding
Time Frame: 12 months
|
Self reports regarding the use of ICPC diagnosis coding for Type 2 Diabetes and Chronic Obstructive Pulmonary Disease.
|
12 months
|
|
Sentinel Data Capture
Time Frame: 12 months
|
Application for the electronic Sentinel Data Capture module for overview of patients with chronic diseases.
|
12 months
|
|
Stratification
Time Frame: 12 months
|
The self reported use of stratification as part of primary care management of patients with chronic diseases
|
12 months
|
|
Change from baseline and at 12 month in practices with low performance on annual systematic chronic disease follow up consultations.
Time Frame: Month 4, 3, 2 before baseline and month 13,14,15 after baseline (after intervention)
|
Reduction in the number of practices with less than 1% annual systematic chronic disease follow up consultations.
|
Month 4, 3, 2 before baseline and month 13,14,15 after baseline (after intervention)
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GP00990002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
Radboud University Medical CenterCompleted
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Outreach visits
-
Universidade Nova de LisboaUnknownGastrointestinal Diseases | Cardiovascular Diseases | Inflammation | Gastroesophageal RefluxPortugal
-
Kaiser PermanenteOregon Health and Science University; University of Washington; Qualis HealthCompletedCardiovascular Disease | Essential Hypertension | Hyperlipidemia | Nicotine DependenceUnited States
-
Duke UniversityDuke Clinical Research Institute; Philips HealthcareRecruiting
-
Kelowna General HospitalCompletedBacterial Infections | Behavior ChangeCanada
-
University of AarhusActive, not recruitingMood | Behavior | Physiological ResponsesDenmark
-
Kaiser PermanenteRecruitingMultiple Chronic Conditions | Social Needs | Care Gaps | NavigationUnited States
-
Canadian Institutes of Health Research (CIHR)Terminated
-
University of PennsylvaniaCompletedCancer of the Colon
-
Harvard Medical School (HMS and HSDM)Humana Co.Ltd.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Cairo UniversityUnknown